Zota Health Care Limited

NSE ZOTA.NS

Zota Health Care Limited Shareholders' Equity for the year ending March 31, 2024: USD 10.79 M

Zota Health Care Limited Shareholders' Equity is USD 10.79 M for the year ending March 31, 2024, a 10.33% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

Zota Health Care Limited Shareholders' Equity for the year ending March 31, 2023 was USD 9.78 M, a -17.17% change year over year.
Zota Health Care Limited Shareholders' Equity for the year ending March 31, 2022 was USD 11.80 M, a 30.37% change year over year.
Zota Health Care Limited Shareholders' Equity for the year ending March 31, 2021 was USD 9.05 M, a -0.87% change year over year.
Zota Health Care Limited Shareholders' Equity for the year ending March 31, 2020 was USD 9.13 M, a -7.91% change year over year.

Key data

Date	Shareholders' Equity	Minority Interest	Total Equity	Total Stockholders Equity and Liabilities

NSE: ZOTA.NS

Zota Health Care Limited

CEO	Dr. Sujit Paul
IPO Date	May 10, 2017
Location	India
Headquarters	Zota House
Employees	445
Sector	Healthcare
Industries Drugstores & Retail Pharmacies Cosmetics Eyewear Personal Care Pharmaceuticals Specialty Retail

Description

Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India. It offers generic drugs, over-the-counter products, ayurvedic products, and nutraceutical products. The company provides various medicines for chronic illnesses, including heart disease, diabetes, thyroid, and others. As of March 31, 2021, it operated 591 retail stores under the DAVAINDIA name in 24 states of India. The company was founded in 1995 and is headquartered in Surat, India.

Key trends

Past 5 years